In the current study, we present evidence that the absence of GCN5L1 promoted hepatic glutaminolysis by increasing GLS1 and GLS2 activities and that this metabolic remodelling increased both mTORC1 activity and HCC cell proliferation in response to chemically induced HCC models. Here, GLS2 is linked to hepatocellular carcinoma.